Clinical trial
Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes
NCT00377676 · VeroScience, Industry · Completed
Key facts
| NCT number | NCT00377676 |
|---|---|
| Title | Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Trial to Assess Safety and Tolerability During Treatment of Type 2 Diabetes (T2DM) With Usual Diabetes Therapy (UDT) and Either Cycloset or Placebo |
| Lead sponsor | VeroScience, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Cycloset, Usual Diabetes Therapy plus placebo |
| Enrollment | 3,095 |
| Start date | Jul 1, 2004 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Sep 18, 2006 |
| Last update posted | Jun 10, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: